Bone Morphogenic Protein signaling in Th/Treg lineage specification
Bone Morphogenic Protein signaling in Th/Treg lineage specification
批准号:
10194972
负责人:
Piotr J. Kraj
金额:
$7.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-02-01 至 2023-01-31
关键词:
Activin ReceptorActivinsAutomobile DrivingBMPR2 geneBindingBiologicalBone Morphogenetic ProteinsCD4 Positive T LymphocytesCell Differentiation processCell LineageCell ProliferationCell physiologyCellsComplexDataEffector CellEpigenetic ProcessExperimental ModelsFOXP3 geneFamilyFamily memberGenerationsGenesGenetic TranscriptionGoalsGrowth FactorHomeostasisImmuneImmune responseImmune systemIn VitroInflammationInflammatoryInterferon Type IIInterleukin-17Knockout MiceMediatingModelingMorphogenesisMusMutant Strains MiceOutcomePeripheralPhenotypePlayPopulationProtein FamilyRegulatory T-LymphocyteReportingResearchResolutionRoleShapesSignal TransductionSignaling ProteinSubgroupT-LymphocyteT-Lymphocyte SubsetsTNF geneTestingTissuesTranscriptional RegulationTransforming Growth Factorsbone morphogenic proteincell behaviorcell motilitycell typecofactorconditional knockoutcross reactivitycytokinedifferential expressionepigenetic regulationepithelial to mesenchymal transitionimmunoregulationinsightmembermorphogensreceptorreceptor bindingresponsetranscriptome
中文摘要
摘要
英文摘要
Abstract
The transforming growth factor-β (TGF-β) family cytokines regulate cell differentiation and morphogenesis, cell
proliferation and migration, epithelial-to-mesenchymal transition and metastatic dissemination. TGF-β is an
immunoregulatory cytokine well known to inhibit activation and differentiation of CD4+ effector cells and promote
suppressor functions of Foxp3+ regulatory T cells. Despite increased understanding of how TGF-β regulates T
cell functions, the immunomodulatory roles of many other members of the TGF-β cytokine family, especially
bone morphogenetic proteins (BMPs), remain largely unknown.
We have found that Bone Morphogenic Protein Receptor 1α (BMPR1α, Alk-3) expressed by naive and
activated CD4+ T cells and Foxp3+ regulatory T (TR) cells, modulates functions effector Th and TR cells.
Abrogating BMPR1α signaling leads to generation of pro-inflammatory Th1/Th17 effector cells expressing high
levels of inflammatory cytokines, IFN-γ, IL-17 and TNF family proteins. BMPR1α-deficient CD4+ T cells do not
generate adaptive TR (aTR) cells. Inactivation of BMPR1α gene in peripheral TR cells reduced Foxp3 expression
leading to the instability of TR phenotype and accumulation of exTR cells. Jmjd3 (Kdm6b) demethylase was
identified as target of BMPR1α signaling in TR cells and epigenetic changes as a cause of lost suppressor
function. We hypothesize that BMPs and BMPR1α may represent regulatory modules shaping epigenetic
landscape and priming T cells for transcriptional regulation mediated by TGF-β.
BMPR1α is not the only receptor binding BMPs, these cytokines may also bind activin receptors including Alk2.
To get further mechanistic insight how BMPs and TGF-β regulate functions of peripheral Th and TR cells we
propose to generate conditional knockout mice where Alk2 gene is deleted in all T cells or in TR cells. Alk2 mutant
mice will be compared to mice lacking BMPR1α gene in the respective T cell subsets. The goal of this proposal
is to produce experimental mice which could be examined to understand how Alk2 and BMPR1α cooperate to
deliver BMP and TGF-β mediated signaling to regulate CD4+ Th and TR cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bone Morphogenic Protein Receptor 1a signaling controls stability of Treg cell phenotype
-
批准号:10727297
-
项目类别:
-
资助金额:$24.8万
-
财政年份:2023
-
负责人:Piotr J. Kraj
-
依托单位:
Modulation of Bone Morphogenic Protein signaling for cancer immunotherapy
-
批准号:8422968
-
项目类别:
-
资助金额:$17.69万
-
财政年份:2012
-
负责人:Piotr J. Kraj
-
依托单位:
Modulation of Bone Morphogenic Protein signaling for cancer immunotherapy
-
批准号:8228616
-
项目类别:
-
资助金额:$22.45万
-
财政年份:2012
-
负责人:Piotr J. Kraj
-
依托单位:
Modulation of Bone Morphogenic Protein signaling for cancer immunotherapy
-
批准号:8977537
-
项目类别:
-
资助金额:$1.09万
-
财政年份:2012
-
负责人:Piotr J. Kraj
-
依托单位:
Modulation of regulatory cell function in cancer immunotherapy
-
批准号:8187283
-
项目类别:
-
资助金额:$30.95万
-
财政年份:2011
-
负责人:Piotr J. Kraj
-
依托单位:
Modulation of regulatory cell function in cancer immunotherapy
-
批准号:8514539
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2011
-
负责人:Piotr J. Kraj
-
依托单位:
Modulation of regulatory cell function in cancer immunotherapy
-
批准号:8708510
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2011
-
负责人:Piotr J. Kraj
-
依托单位:
Modulation of regulatory cell function in cancer immunotherapy
-
批准号:8323881
-
项目类别:
-
资助金额:$31.13万
-
财政年份:2011
-
负责人:Piotr J. Kraj
-
依托单位:
CD4+ T cell subset function in antitumor immune response
-
批准号:7020085
-
项目类别:
-
资助金额:$21.02万
-
财政年份:2005
-
负责人:Piotr J. Kraj
-
依托单位:
CD4+ T cell subset function in antitumor immune response
-
批准号:7564715
-
项目类别:
-
资助金额:$20.41万
-
财政年份:2005
-
负责人:Piotr J. Kraj
-
依托单位:
CD4+ T cell subset function in antitumor immune response
-
批准号:6873587
-
项目类别:
-
资助金额:$21.52万
-
财政年份:2005
-
负责人:Piotr J. Kraj
-
依托单位:
CD4+ T cell subset function in antitumor immune response
-
批准号:7176230
-
项目类别:
-
资助金额:$20.41万
-
财政年份:2005
-
负责人:Piotr J. Kraj
-
依托单位:
CD4+ T cell subset function in antitumor immune response
-
批准号:7345386
-
项目类别:
-
资助金额:$20.41万
-
财政年份:2005
-
负责人:Piotr J. Kraj
-
依托单位:
海外基金